Reinhart Seibl

Reinhart Seibl is a seasoned professional in Regulatory Affairs with extensive experience in the medical device and pharmaceutical industries. Currently serving as Director of Regulatory Affairs at Geistlich Pharma AG since January 2019, Reinhart has previously held pivotal roles at Zimmer Biomet, where responsibilities included managing regulatory support for various global operations and leading teams overseeing regulatory compliance across multiple markets. Reinhart's earlier experience at Institut Straumann AG involved global registrations and project management for regenerative products, while initial research work at ETH Zürich culminated in a PhD focusing on immunology. Reinhart holds a Master of Science degree in Biology from the University of Zurich.